Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (16431)	1/5/2004 1:27:39 PM
From: GARY P GROBBEL	Read Replies (1) \| Respond to of 120415

EMFP .59/.62 vol 100,000: U.S. Army Unit SBCCOM Identifies Numerous Potential Military and Industrial Applications for Emergency Filtration Products' Enhanced 2H Filter Technology Platform Wednesday October 8, 4:09 pm ET HENDERSON, Nev.--(BUSINESS WIRE)--Oct. 8, 2003--Emergency Filtration Products Inc. (EFP) (OTCBB: EMFP - News) announces that it has been participating in a Department of Defense-sponsored research program conducted by California State University (San Bernardino) (CSUSB) for the past eight months. The purpose of the research program has been to determine the potential military and industrial applications of the company's core technology platform, the Enhanced 2H Technology filter system. Over the course of the past eight months, U.S. Soldier and Biological Command (SBCCOM), a unit of the U.S. Army's Army Materiel Command, in conjunction with CSUSB, has been examining how to apply the company's filter technology to a large number of potential applications, including, but not limited to: biohazard masks, transportation (aircraft, tanks, armored personnel carriers) and buildings (military, industrial, office and residential). The program has conducted a number of cost and user needs analyses, economic analyses and technical viability studies of EFP's proprietary Enhanced 2H filter technology. Numerous potential applications of EFP's filter technology have been identified by the U.S. Army. EFP will submit its Enhanced 2H filter technology to a final testing phase that is to be conducted under U.S. Army auspices. Assuming successful completion of this final testing program, EFP will become eligible for a series of grants from the U.S. Army and related agencies. The purpose is to accelerate the commercial development of a number of filter technology applications and allow for rapid procurement by the U.S. Army and other branches of the U.S. armed forces. In addition, EFP will be permitted to market any products that it develops -- subject to governmental approval -- to the private sector. EFP's current product development timetable -- subject to adequate grant funding -- calls for the rapid commercialization of filter-equipped products for the biohazard, transportation, shelter, office building and HVAC (Heating Ventilation and Air Conditioning) markets. Product development for the initial array of products developed under the grant program is expected to take anywhere from three to eight months from grant funding. Grant funding is expected to occur shortly after final U.S. Army testing is completed, assuming successful test results. About SBCCOM The U.S. Army Soldier and Biological Chemical Command provides support in three main areas of defense: research, development and acquisition; emergency preparedness and response; and safe, secure chemical weapons storage, remediation and demilitarization. From the blackboard to the battlefield, SBCCOM provides defense capabilities by fostering partnerships with communities, industry and other government agencies in developing and implementing soldier, chemical and biological defense systems to ensure maximum protection for the United States. About Emergency Filtration Products Inc. EFP is an air filtration products manufacturer whose patented 2H Technology(TM) filter system has produced filtration efficiencies of "greater than 99.99%" at a particulate size of 0.027 microns. Its initial products were developed for the medical market: the Vapor Isolation Valve(TM) and RespAide(TM) CPR Isolation Mask used for resuscitation of respiratory/cardiac arrest cases; and the 2H Breathing Circuit Filter for ventilators, respirators and anesthesia circuitry. Each has received FDA approval. The company also markets an Automated External Defibrillator Prep Kit featuring RespAide and the NanoMask®, a nanotechnology-enhanced environmental mask. In addition to filtration products, the company supplies Superstat®, a modified hemostatic collagen, to the U.S. military for surgery and extreme wound care.